Antiproteinuric Effect of Valsartan and Lisinopril

NCT00171574 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Diabetic Nephropathy

Interventions

DRUG: Valsartan
DRUG: Valsartan plus HCTZ
DRUG: Lisinopril

Sponsor

Novartis